- 29 July 2020
Dr Kevin Fernando summarises results from the cardiovascular outcomes trial of ertugliflozin presented at the American Diabetes Association’s 2020 congress, along with the implications for primary care.
This site is intended for healthcare professionals
The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.
© Oxbridge Solutions Ltd, 2022
Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.
You need to register for GPnotebook Pro in order to track your activity on GPnotebook TV
Would you like to subscribe to our weekly email update containing links to the latest videos on GPnotebook TV?